10 h before follicle rupture, suggesting a unifying role for prostaglandins in the timing of ovulation. However, little is known about prostaglandin production by the primate ovulatory follicle. In this study, adult female macaques received gonadotrophins to promote follicular development. Granulosa cells, follicular fluid, and ovaries were collected before (0 h) and 12, 24 or 36 h after administration of the ovulatory stimulus, human chorionic gonadotrophin (HCG). Cyclooxygenase (COX) isoform expression was assessed by reverse transcription-polymerase chain reaction and immunocytochemistry and follicular prostaglandin production was determined by enzyme immunoassay. COX-2 mRNA expression in granulosa cells was low at 0 h, rose 50-fold by 12 h, and remained elevated through to 36 h. COX-2 immunostaining was present in granulosa cells after, but not before, exposure to HCG. COX-1 mRNA levels did not change during the periovulatory interval, and COX-1 immunostaining of granulosa cells was not detected. Follicular fluid prostaglandin (PG) E 2 and PGF 2α concentrations were low through to 24 h but increased 100-fold at 36 h. The elevated follicular prostaglandin concentrations 4-16 h before the expected time of ovulation support the hypothesis that the time between the LH surge and increased follicular prostaglandins determines the length of the periovulatory period. Differences between the localization and timing of COX-2 expression in monkey versus non-primate follicles suggest that the pattern of COX-2 expression and activity has aspects unique to primates.
Introduction
in follicular fluid of large preovulatory follicles rose dramatically in response to the ovulatory gonadotrophin surge (Wong A critical role for the LH surge in initiating periovulatory and Richards, 1991; Sirois, 1994; Sirois and Dore, 1997) . events in mammals is well established. However, many of the While the interval between the onset of the ovulatory specific gonadotrophin-stimulated processes culminating in gonadotrophin surge and follicle rupture varies for rodents oocyte maturation, follicle rupture, and luteinization of the (14 h), cows (28-30 h), and horses (36-48 h), COX-2 follicle wall are poorly understood. Prostaglandins (PG) are expression in granulosa cells and elevated PG concentrations putative intraovarian mediators of some of the periovulatory occurs in each of these species~10 h before follicle rupture. actions of the ovulatory gonadotrophin surge (Murdoch et al., This observation led Sirois to propose that elevated COX-2 1993). The two isoforms of cyclooxygenase (also known as activity and the resulting increase in follicular fluid PG is the prostaglandin endoperoxide synthase and prostaglandin G/H determining factor controlling the timing of ovulation in synthase), COX-1 and COX-2, which catalyse the rate limiting mammals (Sirois and Dore, 1997) . step in the production of PG (Vane et al., 1998) , are both Prostaglandins appear to play a critical role in follicle present in the mammalian ovary. In rodents and domestic rupture. Deletion of COX-2 gene expression in knockout mice animals, ovarian COX-1 expression was low or non-detectable decreases the number of ovulation sites per ovary (Lim et al., throughout the periovulatory interval (Wong and Richards, 1997) , while mice lacking COX-1 expression have normal 1991; Sirois, 1994; Sirois and Dore, 1997) . In contrast, COX-2 expression by granulosa cells and PG concentrations ovulation and fertilization (Langenbach et al., 1995) . While pierced with a 22-gauge needle, and the aspirated contents of all follicles administration of COX inhibitors prevents ovulation in several Ͼ4 mm in diameter were pooled.
mammalian species including rats (Mikuni et al., 1998) , rabbits
Whole ovaries (n ϭ 2-4/time point) were also obtained from (Zanagnolo et al., 1996) , and sheep (Murdoch, 1996) , limited monkeys undergoing ovarian stimulation. Additional whole ovaries information is available regarding PG production and action (n ϭ 5) were collected from monkeys experiencing spontaneous in primate follicles around the time of ovulation. PGE 2 and menstrual cycles around the expected time of the endogenous LH PGF 2α have been measured in follicular fluid obtained from surge (Weick et al., 1973) . These ovaries were obtained before the women (Jeremy et al., 1987; Priddy et al., 1989) , and the LH surge (n ϭ 2), during the LH surge (n ϭ 2), and after the LH administration of non-selective COX inhibitors to monkeys surge (n ϭ 1) based on serum oestradiol, LH and progesterone (Wallach et al., 1975a) and women (Killick and Elstein, 1987) concentrations before and at the time of organ removal. Rhesus has been shown to block ovulation. However, a causal link monkey testis was obtained at necropsy.
between the ovulatory gonadotrophin surge and stimulation of
Tissue preparation
PG production by the periovulatory follicle has not been Granulosa cells and follicular fluid were obtained from follicular demonstrated for primates. In these studies, we used adult aspirates as described previously (Chaffin et al., 1999a) . Briefly, female rhesus monkeys to determine if the ovulatory gonadotroaspirates were subjected to centrifugation to pellet the granulosa cells, phin surge stimulates COX expression and PG production by and the resulting supernatants (i.e. follicular fluid) were removed and the periovulatory follicle in a temporal manner consistent with stored at -80°C. A granulosa cell-enriched population was obtained a critical role for PG in mediating follicle rupture in primates.
by Percoll gradient centrifugation. Total RNA was obtained from granulosa cells using Trizol reagent according to the manufacturer's (Gibco-BRL, Rockville, MD, USA) instructions and was stored at -20°C. Whole ovaries and testis were fixed in 4% paraformaldehyde
Materials and methods
and embedded in paraffin.
Animals
The general care and housing of rhesus monkeys (Macaca mulatta)
COX-1 and COX-2 mRNA analysis at the Oregon Regional Primate Research Center (ORPRC) were Total RNA (200 ng) was treated with DNase (Gibco-BRL) prior to described previously (Molskness et al., 1987) . Animal protocols and reverse transcription (RT), which was performed using Molony experiments were approved by the ORPRC Animal Care and Use Murine Leukemia Virus reverse transcriptase (Gibco-BRL) as previCommittee, and studies were conducted in accordance with the NIH ously reported (Chaffin et al., 1999b) . Semiquantitative RT-polyGuide for the Care and Use of Laboratory Animals. Adult females merase chain reaction (PCR) based assays similar to those previously with regular menstrual cycles were checked daily for menses, and described by this laboratory (Chaffin et al., 1999b) were developed blood samples were obtained daily from unanaesthetized monkeys to assess COX-1 and COX-2 mRNA levels. Sequences for the by saphenous venipuncture beginning on the first day of treatment.
oligonucleotides (Gibco-BRL) used for PCR are shown in Table I . Serum was stored at -20°C. Serum oestradiol (Resko et al., 1975) The MgCl 2 concentration, amount of cDNA included in each PCR and progesterone (Hess et al., 1981) concentrations were measured reaction, number of PCR cycles, and primer concentrations (for which by radioimmunoassay; intra-and interassay coefficients of variation the amount of co-amplified products for the experimental gene and did not exceed 10%. LH concentrations were determined by the the internal standard gene, cyclophilin, were linear and parallel with mouse Leydig cell bioassay (Ellinwood and Resko, 1980) using an increasing amount of cDNA) were determined empirically for monkey LH RP-1 as the standard (supplied by the NIH Hormone each primer set. The PCR cycle conditions were 92°C for 30 sec, Distribution Program); intra-and interassay coefficients of variation 60°C for 1 min and 72°C for 1 min. The products of both primer for the LH bioassay did not exceed 15%. These assays were performed sets were also in the exponentially increasing phase relative to the by the Endocrine Services Laboratory, ORPRC.
number of PCR cycles. Data are expressed as the ratio of the gene An ovarian stimulation model developed for the collection of of interest to cyclophilin for each sample assayed. Sequence analysis multiple oocytes for IVF (VandeVoort et al., 1989 ) was used to obtain was used to confirm the identity of PCR products. For the regions granulosa cells and follicular fluid (n ϭ 3-5/time point). Beginning amplified in these experiments, the nucleic acid sequences of monkey within 3 days of initiation of menstruation, rhesus monkeys received COX-1 and COX-2 were 99% and 98% identical to the corresponding 60 IU of recombinant human (r-h)FSH (Ares Advanced Technology, human sequences. Amplification using the COX-1 primers yielded Inc., Randolph, MA, USA; days 1-6), followed by 60 IU of r-hFSH two bands, one of which was determined not to be COX-1 by DNA plus 60 IU r-hLH (AAT, Inc.; days 7-9) to stimulate the growth of sequencing. The identity of this PCR product is currently unknown. multiple follicles. Animals also received the gonadotrophin-releasing For this reason, only the band determined to represent COX-1 by hormone antagonist Antide (AAT, Inc.; 0.5 mg/kg body weight) daily sequence analysis was considered in the COX-1 assay; the unidentified to prevent an endogenous ovulatory LH surge. Adequate follicular band did not interfere with quantitative analysis of COX-1 mRNA. development was monitored by serum oestradiol concentrations and PCR products were separated on 2% agarose gels and photographed by ultrasonography (Wolf et al., 1996) . Follicular aspiration was using Polaroid 667 film (Polaroid Corp., Cambridge, MA, USA). For performed on anesthetized animals during aseptic surgery before (0 h) each mRNA, all samples were assayed in duplicate in a single experiment. Intra-assay coefficient of variation was Ͻ15%. and 12, 24 or 36 h after administration of 1000 IU recombinant human chorionic gonadotrophin (HCG) (AAT, Inc.; day 10). In spontaneous PGE 2 and PGF 2α concentrations in follicular fluid menstrual cycles, follicle rupture in rhesus monkeys occurs~40 h after the ovulatory gonadotrophin surge (Weick et al., 1973) , so the Preliminary experiments indicated the presence of a substance in observation times span the periovulatory interval. Previous studies follicular fluid which interfered with the measurement of PG, so all verified ovulation sites on ovaries and oocytes in the oviducts following samples were extracted before assay. Follicular fluids were acidified this protocol (VandeVoort et al., 1989; Hibbert et al., 1996) . To obtain with HCl (final concentration 0.1 mol/l), and Bethesda, MD, USA), which compared band size and intensity to a standard curve and calculated the optical density of each band. All added to each sample, and samples were vortexed vigorously. The phases were allowed to separate at room temperature, and the organic data were assessed for heterogeneity of variance using Bartlett's test and log transformed when necessary. Analyses were performed using layer was then transferred to a fresh tube and dried under nitrogen. Samples were resuspended in assay buffer (from enzyme immunoassay one-way analysis of variance, followed by Newman-Keuls' test when indicated. Data are presented as mean Ϯ SEM, and significance was kit, see below), and an aliquot was subjected to scintillation counting for calculation of PG recovery, which averaged 65%. Concentrations assumed at P Ͻ 0.05. of PGE 2 and PGF 2α in monkey follicular fluid extracts were determined by enzyme immunoassay using commercially available kits
Results
(Cayman Chemical, Ann Arbor, MI, USA), and the PG content of each sample was corrected based on PG recovery calculated for that Cyclooxygenase mRNA expression in periovulatory follicles sample. Intra-and interassay coefficients of variation averaged Ͻ10% COX-2 mRNA levels in granulosa cells changed across the and Ͻ20% respectively. periovulatory interval (Figure 1, upper 
panel). COX-2 mRNA
Immunocytochemical detection of COX-1 and COX-2 levels were low or non-detectable before the administration of Immunocytochemical detection of COX-1 and COX-2 in ovarian the ovulatory dose of HCG (0 h). By 12 h after HCG tissues was performed with paraffin-embedded tissues using mouse administration, COX-2 mRNA levels rose 50-fold over levels monoclonal antibodies generated against sheep COX-1 and a synthetic seen at 0 h (P Ͻ 0.05) and remained elevated through to 36 h. peptide based on the human COX-2 sequence (Cayman Chemical) COX-1 mRNA was detected in all granulosa cell samples (Sekhon et al., 1999) . Briefly, 5 µm tissue sections were deparaffinized obtained at 0, 12 and 36 h after HCG, and the levels did not were also determined. Concentrations of both PGs were low CA, USA). All non-immune serum and antibody incubations were at 0 h and remained low through to 24 h. However, follicular performed in PBS with 0.1% Triton X-100 (Sigma Chemical Co., St fluid concentrations of both PGE 2 and PGF 2α were highest at Louis, MO, USA). Peroxidase was visualized using nickel-DAB 36 h (P Ͻ 0.05), peaking at concentrations Ͼ100-fold greater chromagen (Vector). The COX-1 antibody was used at a concentration than those measured at 24 h. of 10 µg/ml while the COX-2 antibody was used at 3 µg/ml.
Specificity of COX-2 staining was demonstrated by preabsorbing
Cyclooxygenase immunostaining in periovulatory follicles
the antibody overnight at 4°C with the human COX-2 peptide used to generate this antibody at 100-fold excess (Cayman Chemical). An COX-2 immunostaining was detectable in monkey ovaries as appropriate protein for preabsorption of the COX-1 antibody was not a perinuclear or cytoplasmic dark precipitate ( Figure 3A-I) . ( Figure 3D ). Similar results were obtained when the COX-2 antibody was omitted (not shown). These data support the Data analysis specificity of this antibody for detection of the monkey
All gels were scanned, and specific bands were analysed densitometrically using NIH Image 1.40 (Research Services Branch, NIMH, COX-2 protein.
Ovaries were obtained from monkeys undergoing ovarian ( Figure 3C ; n ϭ 4), and strong granulosa and theca cell immunostaining was observed 36 h after HCG administrastimulation before (0 h) and 12, 24 or 36 h after the administration of an ovulatory dose of HCG and processed for tion ( Figure 3D ; n ϭ 4). Primary and secondary follicles as well as antral follicles Ͻ1 mm in diameter consistently immunocytochemical detection of COX-2. In large follicles of ovaries obtained at 0 h ( Figure 3A ; n ϭ 3) or 12 h ( Figure 3B ; lacked COX-2 immunostaining as did the ovarian surface epithelium ( Figure 3F ). In ovaries from animals undergoing n ϭ 2) after HCG administration, granulosa and theca cells showed little or no COX-2 immunoreactivity. Follicles of ovarian stimulation, antral follicles Ͼ2 mm occasionally showed COX-2 immunoreactivity in the theca, but not granulosa, cell ovaries obtained 24 h after HCG consistently showed COX-2 immunostaining in both the granulosa and theca cell layers layer (not shown). COX-2 immunostaining was also examined in five ovaries obtained from monkeys experiencing spontaneous menstrual cycles at times which spanned the periovulatory interval. In the large (Ͼ5 mm) follicle of two ovaries obtained before the ovulatory LH surge, granulosa and theca cells showed little or no COX-2 immunoreactivity ( Figure 3G ). Two ovaries were obtained during the LH surge; both the granulosa and surrounding theca cells of these large follicles showed COX-2 immunoreactivity ( Figure 3H ). An additional ovary was obtained from a monkey with serum hormone concentrations and follicle morphology consistent with the period near the time of follicle rupture. Strong COX-2 immunostaining was observed in the granulosa and theca cells of this large periovulatory follicle ( Figure 3I ). In these five ovaries, the primary, secondary, and antral follicles Ͻ1 mm in diameter were generally devoid of COX-2 immunostaining in both the granulosa and theca cell layers, although staining in the theca cells surrounding larger (2-3 mm) antral follicles was observed ( Figure 3H ).
The specificity of immunocytochemical detection of monkey COX-1 protein was determined using monkey testicular tissue as a control. A dark precipitate representing detection of COX-1 protein was seen in the cytoplasm of epithelial cells of the rete testis, while spermatozoa and seminiferous tubule cells were consistently negative for COX-1 ( Figure 3J ). No staining was observed when the primary antibody was omitted ( Figure 3K ). These findings are consistent with previous reports of immunocytochemical and histochemical localization of COX-1 in the rodent reproductive tract (Johnson and Ellis, 1977; Marshburn et al., 1989) and support the use of this antibody for COX-1 detection in monkey tissues.
In monkey ovaries, COX-1 protein was not detected in the Representative gels are shown for each mRNA. mRNA of interest was co-amplified with the internal standard cyclophilin (CYC), and data were expressed as relative units. For each mRNA, levels at 0 h were arbitrarily set at equal to 1.0. Within each panel, groups with different superscripts are significantly different by analysis of variance and Newman-Keuls' test, P Ͻ 0.05. Data are expressed as mean Ϯ SEM; n ϭ 3/group. COX-1 mRNA levels at 24 h could not be determined (ND); see text for details. In the lower panel, the arrow indicates the position of a band determined not to be COX-1 by DNA sequencing; this band was not included in analysis of COX-1 expression.
primates. Levels of COX-1 mRNA in monkey granulosa cells of large antral follicles did not change across the periovulatory interval, and COX-1 protein was not detected in the granulosa or theca cells of these same follicles. These data suggest that COX-1 is not a major source of PG in primate periovulatory follicles and are consistent with results from other mammalian species (Wong and Richards, 1991; Sirois, 1994; Sirois and Dore, 1997) . COX-2 mRNA and protein concentrations increased in response to an ovulatory dose of gonadotrophin, and follicular fluid concentrations of PGE 2 and PGF 2α rose between 24 and 36 h after HCG administration. These data are comparable to changes in COX-2 expression and follicular fluid PG seen in other mammalian species (Wong and Richards, 1991; Sirois, 1994; Sirois and Dore, 1997) , consistent with the hypothesis that the time between the ovulatory gonadotrophin surge and increased follicular PG production determines the length of the periovulatory interval (Sirois and Dore, 1997) . However, the interval between initiation of COX-2 expression and the periovulatory rise in follicular fluid PG concentrations appears to be longer in primates than in other mammalian species. In addition, COX-2 was present in the theca, as well as granulosa, cells of the periovulatory follicle, in contrast with reports of an absence of COX-2 expression in the theca of domestic animals (Liu et al., 1997; Sirois and Dore, 1997) . This disparity in both the temporal expression and localization of COX-2 between primates and other mammalian species suggests that important differences exist in the pathway regulating hormonal induction of COX-2 expression and modulation of PG production in periovulatory follicles. COX-2 expression and PG production by the granulosa cells of primate periovulatory follicles appears to differ somewhat from that reported for rodents and domestic animals. In these other species, granulosa cell COX-2 mRNA and protein concentrations increase~10 h before follicle rupture, with elevated follicular fluid PG concentrations being measured Figure 2 . Concentrations of prostaglandin (PG) E 2 and PGF 2α in~4 h before ovulation (Wong and Richards, 1991; Sirois, 1994;  follicular fluid from rhesus monkeys during ovarian stimulation Sirois and Dore, 1997) . A different pattern was seen in the cycles before and after human chorionic gonadotrophin (HCG) monkey (present study). COX-2 mRNA levels increased~28 h component(s) of the PG synthetic pathway other than COX-2 may limit PG production during these early hours of the granulosa cells or stroma surrounding the follicles in any tissue periovulatory interval in primates. COX-2 protein was detected section examined ( Figure 3L and data not shown). This in the granulosa cells of follicles obtained from monkeys included primary, secondary, antral, large preovulatory, and experiencing natural menstrual cycles after, but not before, the periovulatory follicles from monkeys undergoing ovarian endogenous LH surge. These data are consistent with the stimulation or experiencing spontaneous menstrual cycles.
pattern of COX-2 expression in ovaries from monkeys under-COX-1 immunoreactivity was however observed in the ovarian going ovarian stimulation and support the use of this model surface epithelium ( Figure 3L ), and this immunoreactivity was in future experiments. not seen when the COX-1 antibody was omitted ( Figure 3M ). COX-2 protein was first detected in the theca surrounding monkey periovulatory follicles 24-36 h after HCG administraDiscussion tion as well as after the initiation of the endogenous LH surge in natural cycles. This observation is consistent with This study is the first to demonstrate a temporal relationship between the ovulatory gonadotrophin surge, COX-2 expression descriptions of cyclooxygenase activity in human theca cells (Patwardhan and Lanthier, 1981) but is in contrast to previous by the periovulatory follicle, and follicular PG production in reports of an absence of COX-2 protein in theca cells of role in the growth, development, or rupture of the primate follicle. domestic animals (Liu et al., 1997; Sirois and Dore, 1997) . COX-2 was also present in theca cells surrounding some COX-2 expression and PG production are regulated by several pathways in ovarian granulosa cells. In the non-primate small antral follicles both before and after the ovulatory gonadotrophin surge, suggesting that exposure to high gonadspecies studied to date, ovulatory doses of gonadotrophin are required to initiate COX-2 expression in granulosa cells; lower otrophin concentrations may not be required for COX-2 expression in these cells. While it is unknown if PG of thecal concentrations of FSH and LH present during natural and gonadotrophin-stimulated cycles which support follicular origin contribute to the periovulatory rise in follicular fluid PG concentrations, theca-derived PG may play an important development do not initiate COX-2 expression in these species (Sirois, 1994; Liu et al., 1997; Dore, 1997). A 1987; Mikuni et al., 1998) ; ovulation can be restored by PGE 2 or PGF 2α co-administration (Hamada et al., 1978; Sogn et al., cAMP- response element has been found in the promoter region of the rat (Sirois et al., 1993) and human (Kosaka et al., 1994) 1987). Mice lacking COX-2 have a decreased rate of ovulation (Lim et al., 1997) due, at least in part, to a defect in follicle COX-2 genes, consistent with activation of COX-2 gene expression through the LH/HCG receptor. Recently, forskolin rupture that can be restored with exogenous administration of PGE 2 (Davis et al., 1999) . Further support for a key role for treatment was shown to increase COX-2 expression by bovine granulosa cells in vitro, demonstrating a direct relationship PGs in follicle rupture comes from studies showing that inhibition of PG production reduces the gonadotrophinbetween elevated intracellular cAMP and initiation of COX-2 expression in these cells (Liu et al., 2000) . Other mediators stimulated rise in proteolytic enzymes involved in follicle rupture in rats (Reich et al., 1991) . However, normal or nearcan also modulate COX-2 expression or activity in granulosa cells. Interleukin-1 (IL-1) has been seen to stimulate COX-2 normal ovulatory efficiency has been observed in knockout mice lacking specific receptors for PGE 2 (Hizaki et al., 1999 ; expression in dispersed cells from the rat ovary (Ando et al., 1998) and human luteinizing granulosa cells (Narko et al., Tilley et al., 1999) or PGF 2α (Sugimoto et al., 1997) , so the PG(s) involved in mediating gonadotrophin-stimulated 1997) in vitro. Nitric oxide can enhance PG production by rabbit periovulatory follicles (Yamauchi et al., 1997) , most follicle rupture remain unknown. Defects in cumulus expansion have also been noted in knockout mice lacking expression of likely through a mechanism other than regulation of COX-2 synthesis (Goodwin et al., 1999) . Progesterone can decrease COX-2 (Davis et al., 1999) or the PGE receptor, EP2 (Hizaki et al., 1999; Tilley et al., 1999) , suggesting an additional COX-2 expression by rat granulosa cells in vitro with equivocal effects on PG production (Hellberg et al., 1996; Hedin and pathway by which PGs may reduce fertility. In monkeys (Wallach et al., 1975a) and women (Killick and Elstein, 1987) Eriksson, 1997). However, no apparent effect of periovulatory progesterone depletion (Chaffin and Stouffer, 1999) has been receiving non-selective COX inhibitors, normal luteal phase progesterone has been observed along with an increased observed on monkey granulosa cell COX-2 mRNA and follicular fluid PG concentrations (Duffy and Stouffer, unpublished incidence of luteinized unruptured follicles, suggesting that rupture, and not luteinization, was altered by PG synthesis data). While it is clear that the ovulatory gonadotrophin surge initiates granulosa cell COX-2 expression in several inhibition in primates. The detection of COX-1 in the ovarian surface epithelium supports the hypothesis that prostaglandins mammalian species, further study is needed to understand how intraovarian factors modulate COX-2 expression and activity produced by these cells may play a role in ovulation. Studies in sheep suggest that doses of indomethacin which inhibit as well as PG synthesis by the primate periovulatory follicle.
Follicular PGs may play an important role in many periovulaovulation also prevent apoptosis of ovarian surface epithelium covering the follicle apex, a process thought to be essential tory processes. Administration of non-selective COX inhibitors to monkeys (Wallach et al., 1975a) and women (Killick and for follicle rupture (Murdoch, 1996) . Collectively, these reports and current data indicate that PGs are likely mediators of Elstein, 1987) has been shown to prevent ovulation; this effect could be reversed in monkeys by simultaneous administration follicle rupture in primates. However, identification of individual PGs and their specific roles in the regulation of of PGF 2α (Wallach et al., 1975b) . A recent report of reversible infertility in women taking COX inhibitors for treatment of various periovulatory processes awaits further study.
In summary, we have demonstrated in the rhesus monkey arthritic symptoms also supports the critical role of cyclooxygenase activity in reproductive processes (Mendonca et al., that the periovulatory follicle expresses COX-2 and produces PGs in response to an ovulatory dose of gonadotrophin. These 2000). In rodents, non-selective or COX-2-specific PG synthesis inhibitors can also prevent ovulation when administered data are consistent with a role for PGs in mediating the action of the LH surge to trigger follicle rupture. The ovulatory LH systemically (Tsafriri et al., 1972; Mikuni et al., 1998) or to perfused whole ovaries (Hamada et al., 1978; Sogn et al., surge appears to be essential for COX-2 expression in the Figure 3 . Immunocytochemical detection of cyclooxygenase (COX)-2 and COX-1 in monkey tissues. In follicles obtained from monkeys undergoing ovarian stimulation, the dark cytoplasmic precipitate representing COX-2 immunostaining was only occasionally seen before (0 h; A) and 12 h after (B) human chorionic gonadotrophin (HCG) administration. COX-2 immunostaining was present in both the granulosa and theca cells 24 h (C) and 36 h (D) after HCG administration. In panels A, C and D, black asterisks indicate the location of the granulosa cell layer and arrowheads indicate theca cells. During natural menstrual cycles before exposure to an endogenous LH surge, granulosa and theca cells occasionally stained weakly for COX-2 (G). However, COX-2 immunostaining was consistently observed in granulosa and theca (arrowhead) cells during (H) and after (I) the endogenous LH surge. COX-2 immunostaining was observed in a monkey periovulatory follicle when the primary antibody for COX-2 was included (D), but immunostaining was not evident in an adjacent section when the COX-2 primary antibody was preabsorbed with the human COX-2 peptide used to generate the antibody (E). COX-2 immunostaining was not observed in the ovarian surface epithelium or in granulosa or theca cells of primary, secondary, and small antral follicles Ͻ1 mm in diameter (F). However, theca cells of small antral follicles 2-3 mm in diameter (saf) did show COX-2 immunoreactivity during the LH surge (H). In the testis (J), dark cytoplasmic deposits representing COX-1 immunostaining were observed in the epithelial cells of the rete testis (arrow) but not seminiferous tubule (white asterisk). No staining was observed in the rete testis (arrow) or tubules (white asterisk) when the primary antibody was omitted (K). COX-1 immunostaining was present in the ovarian surface epithelium (arrow) but was not evident in granulosa or theca cells of primary, secondary, or antral follicles (L). Omission of the primary antibody yielded no staining of the surface epithelium (arrow) on an adjacent tissue section (M). All panels use scale bar in M: A-E and G-I, bar ϭ 5 µm; F and J-M, bar ϭ 10 µm.
